Clinical Trial Update: Surveillance Study of Women Taking Intrinsa®

View source ↗

Summary

The surveillance study of women taking Intrinsa (testosterone transdermal patch) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoactive Sexual Desire Disorder

Drugs mentioned

• Intrinsa (testosterone)

Snippet

Sponsor: Center for Epidemiology and Health Research, Germany | Conditions: Ovariectomy, Hysterectomy | Status: TERMINATED